Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-hydroxyphenyl ketones as potential inhibitors of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3).
Rupinder K Lota, Sachin Dhanani, Caroline P Owen, Sabbir Ahmed
Index: Bioorg. Med. Chem. Lett. 16 , 4519-22, (2006)
Full Text: HTML
Abstract
We report the preliminary results of the synthesis and biochemical evaluation of a number of 4-hydroxyphenyl ketones as inhibitors of the isozyme of the enzyme 17beta-hydroxysteroid dehydrogenase (17beta-HSD) responsible for the conversion of androstenedione (AD) to testosterone (T), more specifically type 3 (17beta-HSD3). The results of our study suggest that we have synthesised compounds which are, in general, potent inhibitors of 17beta-HSD3, in particular, we discovered that 1-(4-hydroxy-phenyl)-nonan-1-one (8) was the most potent (IC(50) = 2.86 +/- 0.03 microM). We have therefore provided good lead compounds in the synthesis of novel non-steroidal inhibitors of 17beta-HSD3.
Related Compounds
Related Articles:
A nicotinic receptor-mediated anti-inflammatory effect of the flavonoid rhamnetin in BV2 microglia.
2014-10-01
[Fitoterapia 98 , 11-21, (2014)]
2015-04-15
[Food Chem. 173 , 607-18, (2014)]
In vitro sensitization of erythrocytes to programmed cell death following baicalein treatment.
2014-09-01
[Toxins (Basel.) 6(9) , 2771-86, (2014)]
2016-01-01
[Biol. Pharm. Bull. 39 , 181-91, (2016)]
2013-09-15
[Int. J. Pharm. 454(1) , 125-34, (2013)]